Click to login and read the full article.
Don’t have access? Click here to request a demo
Alternatively, Call a member of the team to discuss membership options
US and Overseas: +1 646-931-9045
UK: 0207 139 1600
Abstract
Buyers of OTC derivatives need to be concerned about both market risk from the contract’s underlying asset and credit risk of the derivatives counterparty. Taking counterparty risk into valuation leads to Credit Value Adjustment (CVA), which is now recognized as a necessary factor in the calculation of regulatory capital. Wrong way risk occurs when the counterparty’s credit quality is correlated with the value of the derivative contract, so that the counterparty’s default risk increases just when its liability under the contract goes up. Under Basel III, required capital is increased for wrong way risk. In this article, Ghamami and Goldberg question whether that treatment is appropriate. The authors show that CVA may actually be lower than independent CVA in theory, and they provide a numerical example showing that the parameter values for this to occur in practice are not unreasonable.
- © 2014 Pageant Media Ltd
Don’t have access? Click here to request a demo
Alternatively, Call a member of the team to discuss membership options
US and Overseas: +1 646-931-9045
UK: 0207 139 1600